The deleterious health effects that result from long-term tobacco addiction extract an enormous socioeconomic cost each year, yet astonishingly little is known about the causes of tobacco, or more appropriately, nicotine addiction. Nicotine use and/or treatment elicits a broad array of behavioral and physiological effects that presumably arise subsequent to the binding of nicotine to brain nicotinic cholinergic receptors (nAChR). Brain nAChRs are ligand-gated ion channels that are readily activated and desensitized by nicotinic agonists. Molecular approaches have identified 10 genes that encode for nAChR subunits. The mRNAs for some of these subunits are expressed in many brain regions whereas others appear to be expressed in only a few. The studies outlined in this proposal will attempt, using neurochemical and genetic strategies, to identify the subunit composition of nAChRs that make up several different ligand binding sites and regulate presynaptic processes such as ion flux and neurotransmitter release. These studies will make use of several null mutant (knockout) mice that have specific nAChR subunit genes disrupted. Other studies will assess the effects of chronic nicotine treatment on the number and function of mouse brain nAChRs. Experiments done with cell lines expressing neuronal-type nAChRs have demonstrated that chronic nicotine treatment elicits a permanent inactivation of receptor function. The chronic studies outlined in this proposal will evaluate whether a similar phenomenon occurs in mammalian brain, and whether this effect varies across brain regions and receptor subtype. The information provided will also be useful in testing the hypothesis that changes in nAChR number and function underlie tolerance and dependence on nicotine.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA003194-19
Application #
6378366
Study Section
Special Emphasis Panel (ZRG1-BDCN-6 (02))
Program Officer
Satterlee, John S
Project Start
1983-09-30
Project End
2004-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
19
Fiscal Year
2001
Total Cost
$265,264
Indirect Cost
Name
University of Colorado at Boulder
Department
Genetics
Type
Other Domestic Higher Education
DUNS #
City
Boulder
State
CO
Country
United States
Zip Code
80309
Semenova, Svetlana; Jin, Xinchun; McClure-Begley, Tristan D et al. (2018) Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of ?4?2* nAChRs in Wistar male rats. Pharmacol Biochem Behav 171:54-65
Moretti, Milena; Fasoli, Francesca; Gotti, Cecilia et al. (2018) Reduced ?4 subunit expression in ?4+- and ?4+- /?2+- nicotinic acetylcholine receptors alters ?4?2 subtype up-regulation following chronic nicotine treatment. Br J Pharmacol 175:1944-1956
Locker, Alicia R; Marks, Michael J; Kamens, Helen M et al. (2016) Exposure to nicotine increases nicotinic acetylcholine receptor density in the reward pathway and binge ethanol consumption in C57BL/6J adolescent female mice. Brain Res Bull 123:13-22
McClure-Begley, Tristan D; Esterlis, Irina; Stone, Kathryn L et al. (2016) Evaluation of the Nicotinic Acetylcholine Receptor-Associated Proteome at Baseline and Following Nicotine Exposure in Human and Mouse Cortex. eNeuro 3:
Pistillo, Francesco; Fasoli, Francesca; Moretti, Milena et al. (2016) Chronic nicotine and withdrawal affect glutamatergic but not nicotinic receptor expression in the mesocorticolimbic pathway in a region-specific manner. Pharmacol Res 103:167-76
Fasoli, F; Moretti, M; Zoli, M et al. (2016) In vivo chronic nicotine exposure differentially and reversibly affects upregulation and stoichiometry of ?4?2 nicotinic receptors in cortex and thalamus. Neuropharmacology 108:324-31
Marks, Michael J; O'Neill, Heidi C; Wynalda-Camozzi, Kelly M et al. (2015) Chronic treatment with varenicline changes expression of four nAChR binding sites in mice. Neuropharmacology 99:142-55
Sanjakdar, Sarah S; Maldoon, Pretal P; Marks, Michael J et al. (2015) Differential roles of ?6?2* and ?4?2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice. Neuropsychopharmacology 40:350-60
Meyers, Erin E; Loetz, Esteban C; Marks, Michael J (2015) Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment. Pharmacol Biochem Behav 130:1-8
Carroll, F Ivy; Navarro, Hernán A; Mascarella, S Wayne et al. (2015) In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at ?6?2 containing neuronal nicotinic acetylcholine receptors. ACS Chem Neurosci 6:920-6

Showing the most recent 10 out of 140 publications